Biotechnology ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan November 3, 2020
Biotechnology Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases November 3, 2020
Biotechnology Axsome Therapeutics to Present Data from the ADVANCE-1 Trial of AXS-05 in Alzheimer’s Disease Agitation at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference November 3, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline - BMRN November 2, 2020
Biotechnology Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates November 2, 2020
Biotechnology Reata Pharmaceuticals, Inc. to Report Third Quarter 2020 Financial Results and Provide an Update on Development Programs on November 9, 2020 November 2, 2020
Biotechnology Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11 November 2, 2020
Biotechnology Halozyme Reports Third Quarter 2020 Results And Raises Full Year 2020 Guidance November 2, 2020
Biotechnology EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS November 2, 2020
Search
Biotechnology
